Ovagen (Glu-Asp-Leu) is a synthetic tripeptide from Vladimir Khavinson’s bioregulatory peptide program. It is classified as a hepatic and gastrointestinal bioregulator. Published research consists primarily of Russian-language preclinical studies examining effects on liver tissue and digestive function. No controlled human trials have been published in English-language peer-reviewed journals.

📖 Read the full Ovagen research overview →

Evidence Tier: Tier 4 — Preclinical Only · Peptidings Verdict: Thin Ice